This Article Full Text Full Text (PDF) All Versions of this Article: 36/8/1656    most recent 01.STR.0000173173.38289.69v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gormley, K. Articles by Markus, H. S. Search for Related Content PubMed PubMed Citation Articles by Gormley, K. Articles by Markus, H. S. Related Collections Endothelium/vascular type/nitric oxide Genetics of Stroke

(Stroke. 2005;36:1656.)
© 2005 American Heart Association, Inc.

Original Contributions

Polymorphisms in Genes of the Endothelin System and Cerebral Small-Vessel Disease

From the Department of Clinical Neuroscience, St George’s Hospital Medical School, St George’s Hospital, London, England.

Correspondence to Prof Hugh Markus, Clinical Neuroscience, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail h.markus{at}sghms.ac.uk

Background and Purpose— Endothelial dysfunction has been implicated in the pathogenesis of cerebral small-vessel disease (SVD). Endothelin (ET), released by the endothelium, plays a crucial role in vasoconstriction in the cerebral circulation and could contribute to the pathogenesis of cerebral SVD. Circulating ET levels may not reflect vascular production of endothelin-1 (ET-1), most of which is abluminal. Studying genetic associations, particularly of functional polymorphisms that alter activity of the ET system, is an attractive method of determining whether ET plays a role in SVD pathogenesis. We determined whether genetic variants in components of the ET system are a risk factor for cerebral SVD.

Methods— Three hundred SVD patients and 600 community controls were genotyped. Polymorphisms in the ET-1 gene (K198N), the ET receptor type A (ET_A), (–231G>A and +1222C>T), and the ET type B (ET_B) receptor (G57S and L277L) were genotyped. Polymorphisms were studied both individually and as haplotypes. With brain imaging, cases were subtyped into those with lacunar infarct without leukoaraiosis and those with leukoaraiosis.

Results— No significant differences were observed between SVD cases and controls for any individual single-nucleotide polymorphism or the ET_A haplotype. There were no differences between cases with isolated lacunar infarct or with lacunar infarct and leukoaraiosis.

Conclusions— This study, in a well-phenotyped population, does not support a role for genetic variation in the ET system as a risk factor for cerebral SVD.

Key Words: endothelins • genetics • small-vessel disease • stroke

This article has been cited by other articles:

				H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]

				G. P. ROSSI and G. PITTER Genetic Variation in the Endothelin System: Do Polymorphisms Affect the Therapeutic Strategies? Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 34 - 50. [Abstract] [Full Text] [PDF]